skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines human coagulation factor VIIIQuestion & answer

human coagulation factor VIII · Medicine question

By what route is Optivate administered?

iatroX medicinesPublished 8 November 2026

The answer

Answer

Optivate is administered intravenously at a rate not exceeding 3 ml per minute.

Sources for this answer

Optivate powder and solvent for solution for injectionBio Products Laboratory Limited · emc · SmPC §4.2 Posology and method of administration · Version 11Document updated 26 August 2026

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

More questions about human coagulation factor VIII

Are headache and drowsiness common side effects of Optivate?Can the risk of transmitting infectious agents through Optivate be completely excluded?How much sodium does Optivate contain per millilitre?Can human coagulation factor VIII be used during pregnancy or breastfeeding?Can human coagulation factor VIII replacement therapy increase cardiovascular risk in patients with existing cardiovascular risk factors?

human coagulation factor VIII

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the human coagulation factor VIII guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX

How does human coagulation factor VIII help blood clots form?